FMO5 and coronary artery disorder: Assuming that the causes of death in the CAD patient population are mainly acute coronary syndromes and their complications, patients who express NADPH oxidase encoded by the CYBA 214TT genotype may have a lower probability of suffering a fatal acute coronary syndrome (ACS).